Health Technology · Pharmaceuticals: Major · NSE: PRAVEG · data 2026-10-09

Praveg Limited

Health check: Weak (2/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹235.95

Market cap

₹615 cr

P/E

—

P/B

—

ROE

-2.5%

ROCE

1.6%

Debt / equity

0.38

Dividend yield

0.21%

1-year return

-12.9%

52-week high

₹325

52-week low

₹210.4

Operating margin

1.3%

Growth

Revenue (last 12 months)	₹248 cr
Net profit (last 12 months)	₹-19 cr
Sales growth, 3 years (yearly)	41.8%
Profit growth, 3 years (yearly)	—

Similar companies

Anuh Pharma Limited (ANUHPHR) · Amanta Healthcare Limited (AMANTA) · Wanbury Limited (WANBURY) · Valiant Laboratories Ltd. (VALIANTLAB) · Infinium Pharmachem Ltd. (INFINIUM)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open PRAVEG in NSE Scanner →